デフォルト表紙
市場調査レポート
商品コード
1428335

心臓病向けAIの世界市場レポート 2024

Artificial Intelligence In Cardiology Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心臓病向けAIの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

心臓病向けAIの市場規模は、今後数年間で急激に成長すると予想されています。 2028年には39.2%の年間複合成長率(CAGR)で75億3,000万米ドルに成長すると予想されます。予測期間中に予想される拡大は、電子医療記録との統合、人口の高齢化、ウェアラブルデバイスの利用、遠隔監視、遠隔心臓学の世界の導入、心臓血管画像の統合によるものと考えられます。予測期間中に予想される主な動向には、心臓血管診断における技術革新、AIアルゴリズムの進歩、新薬製剤の開発、医療画像処理の進歩などが含まれます。

心血管疾患の有病率の予想される増加により、将来、心臓病学市場における人工知能が推進されると予想されます。心血管疾患には、心臓と血管に影響を及ぼすさまざまな状態が含まれます。心臓病学の分野では、AIは心電図(ECG)の解釈を支援し、QT延長症候群や心房細動などの状態を特定することにより、病気の検出において重要な役割を果たしています。さらに、AIは電子医療記録、モバイル健康デバイス、画像データからの広範なデータを分析できます。たとえば、米国心臓協会による2022年 1月の論文では、2022年の世界の心血管疾患による死亡者数は約1,910万人であると報告されています。さらに、疾病管理予防センターの2023年 5月の報告では、世界の心臓病関連死亡の増加が明らかになりました。米国では、 2019年の659,041人から2021年には695,000人に増加しました。このように、心血管疾患の世界的負担は心臓病向けAI市場の原動力となっています。

ウェアラブルデバイスの採用の増加により、今後数年間で心臓病向けAI市場の成長が促進される見込みです。一般にウェアラブルとして知られるウェアラブルデバイスは、さまざまなデータポイントを収集および監視するためのセンサー、ネットワーク機能、および処理機能を備えた電子アクセサリーまたは衣料品です。 AIアルゴリズムはウェアラブルからのデータを分析し、不整脈、心不全、脳卒中などの潜在的な心臓の問題を示す微妙な異常を検出できます。たとえば、HeadphonesAddictの2023年 2月のレポートによると、Apple Inc.は2021年に約4,000万台のApple Watchを販売し、前年比29%増加しました。したがって、ウェアラブルデバイスの人気の高まりが心臓病向けAI市場の促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 心臓病向けAIの世界市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ハードウェア
  • ソフトウェアソリューション
  • サービス
  • 心臓病向けAIの世界市場、アプリケーション別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 心不整脈
  • 脳卒中
  • 虚血性心疾患または冠動脈疾患(CAD)
  • その他
  • 心臓病向けAIの世界市場、最終用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ライフサイエンス企業
  • 医療支払者
  • 医療提供者

第7章 地域および国の分析

  • 心臓病向けAIの世界市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 心臓病向けAIの世界市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 心臓病向けAI市場の競合情勢
  • 心臓病向けAI市場の企業プロファイル
    • Microsoft Corporation
    • International Business Machines Corporation
    • Siemens Healthineers
    • Koninklijke Philips
    • Tempus Labs Inc.

第31章 その他の大手および革新的な企業

  • Ultromics Ltd
  • Bay Labs
  • Cleerly Inc.
  • RSIP Vision Ltd.
  • Idoven
  • Cardiologs Technologies Inc.
  • Viz.ai
  • Ultromics Limited
  • Aidoc
  • Arterys Inc.
  • Zebra Medical Vision
  • Vista.ai
  • AliveCor
  • DiA Imaging Analysis
  • Eko Health Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14180

Artificial intelligence is applied in cardiology to predict cardiovascular outcomes, identify malignant arrhythmias, and non-invasively diagnose coronary artery disease. Its use encompasses the detection of heart disease, prompt stroke treatment, and the improvement of diagnostic radiology capabilities.

The essential components of artificial intelligence in cardiology include hardware, software solutions, and services. Hardware pertains to the components or delivery mechanisms responsible for storing and executing written instructions from specific software. In cardiology, artificial intelligence hardware is employed in treating various cardiovascular diseases, such as cardiac arrhythmia, stroke, ischemic heart disease, and coronary artery disease (CAD). Life science companies, healthcare payers, and healthcare providers utilize these technologies.

The artificial intelligence in cardiology research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cardiology market statistics, including the artificial intelligence in cardiology industry's global market size, regional shares, competitors with an artificial intelligence in cardiology market share, detailed artificial intelligence in cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cardiology industry. This artificial intelligence in cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in cardiology market size has grown exponentially in recent years. It will grow from $1.44 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 39.2%. The rise during the historical period can be linked to a growing burden of cardiovascular diseases, the accessibility of big data, clinical decision support, the increasing significance of preventive cardiology, and shortages in cardiovascular specialists.

The artificial intelligence in cardiology market size is expected to see exponential growth in the next few years. It will grow to $7.53 billion in 2028 at a compound annual growth rate (CAGR) of 39.2%. The expansion anticipated in the forecast period can be ascribed to the integration with electronic health records, the aging population, the utilization of wearable devices, remote monitoring, the global adoption of telecardiology, and the integration of cardiovascular imaging. Key trends expected in the forecast period encompass technological innovations in cardiovascular diagnostics, advancements in AI algorithms, developments in new drug formulations, and progress in medical imaging.

The anticipated rise in the prevalence of cardiovascular diseases is expected to drive the artificial intelligence in the cardiology market in the future. Cardiovascular diseases encompass various conditions affecting the heart and blood vessels. In the field of cardiology, AI plays a crucial role in disease detection by assisting in electrocardiogram (ECG) interpretation and identifying conditions such as long QT syndrome and atrial fibrillation. Additionally, AI can analyze extensive data from electronic health records, mobile health devices, and imaging data. For instance, a January 2022 article by the American Heart Association reported approximately 19.1 million global deaths attributed to cardiovascular disease in 2022. Furthermore, a May 2023 report from the Centers for Disease Control and Prevention revealed an increase in heart disease-related deaths in the US from 659,041 in 2019 to 695,000 in 2021. Thus, the global burden of cardiovascular diseases is a driving force for the artificial intelligence in cardiology market.

The increasing adoption of wearable devices is poised to fuel the growth of the artificial intelligence in cardiology market in the upcoming years. Wearable devices, commonly known as wearables, are electronic accessories or clothing items equipped with sensors, networking capabilities, and processing features to collect and monitor various data points. AI algorithms can analyze data from wearables to detect subtle abnormalities indicative of potential heart issues, such as arrhythmias, heart failure, and strokes. For instance, according to a February 2023 report by HeadphonesAddict, Apple Inc. sold approximately 40 million Apple Watches in 2021, marking a 29% increase from the previous year. Hence, the increasing popularity of wearable devices is a driving factor for the artificial intelligence in cardiology market.

The emergence of new AI-powered cardiology products is a notable trend in the artificial intelligence in cardiology market. Key companies in this market are dedicated to developing innovative AI-powered products for cardiology to strengthen their market position. For example, in February 2023, Eko Health, a US-based digital health company, introduced SENSORA, a digital stethoscope platform designed for detecting heart and lung diseases. SENSORA utilizes advanced machine learning and artificial intelligence to identify structural murmurs, a key indicator of valvular heart disease. This platform combines a stethoscope, one of the most widely used medical instruments globally, with the latest developments in applied machine learning for cardiovascular disease detection.

Major players in the artificial intelligence in cardiology market are actively pursuing strategic collaborations to revolutionize heart research. Strategic partnerships involve leveraging each other's strengths and resources for mutual benefits and success. For instance, in October 2023, the Icahn School of Medicine at Mount Sinai, a US-based medical school, announced a collaboration with Chiba Institute of Technology (CIT), a Japan-based private university. This collaboration aims to enhance knowledge, mitigation, and management of cardiovascular disease, as well as develop novel approaches to address this global health concern. Mount Sinai and CIT will collaborate on global clinical studies using artificial intelligence in interventional cardiology, heart failure, cardiac electrophysiology, cardiac imaging, and preventive cardiology. The research will also focus on reducing gender and race bias at the intersection of artificial intelligence and cardiovascular research to enhance patient care and outcomes.

In November 2022, Anumana, a US-based AI-driven health technology company, acquired NeuTrace for an undisclosed amount. This acquisition aims to position Anumana as a leader in AI medical software development for cardiac electrophysiology and expand the company's product portfolio. NeuTrace, a US-based medical device company, specializes in AI and Machine Learning to develop innovative diagnostics and solutions for heart disease.

Major companies operating in the artificial intelligence in cardiology market report are Microsoft Corporation, International Business Machines Corporation, Siemens Healthineers, Koninklijke Philips, Tempus Labs Inc., Ultromics Ltd, Bay Labs, Cleerly Inc., RSIP Vision Ltd., Idoven, Cardiologs Technologies Inc., Viz.ai, Ultromics Limited, Aidoc, Arterys Inc., Zebra Medical Vision, Vista.ai, AliveCor, DiA Imaging Analysis, Eko Health Inc., Cardiomatics, CardiAi Inc., UltraSight, Anumana Inc., Cardiai Inc.

North America was the largest region in the artificial intelligence in cardiology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence in cardiology market consists of revenues earned by entities by providing disease prediction, disease diagnosis, and automation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence market in cardiology also includes sales of smart robots, and imaging tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Cardiology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Component: Hardware; Software Solutions; Services
  • 2) By Application: Cardiac Arrhythmia; Stroke; Ischemic Heart Disease Or Coronary Artery Disease (CAD); Other Applications
  • 3) By End-Use: Lifescience Companies; Healthcare Payers; Healthcare Providers
  • Companies Mentioned: Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Tempus Labs Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Cardiology Market Characteristics

3. Artificial Intelligence In Cardiology Market Trends And Strategies

4. Artificial Intelligence In Cardiology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Intelligence In Cardiology Market Size and Growth

  • 5.1. Global Artificial Intelligence In Cardiology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Intelligence In Cardiology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Intelligence In Cardiology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Intelligence In Cardiology Market Segmentation

  • 6.1. Global Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hardware
  • Software Solutions
  • Services
  • 6.2. Global Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiac Arrhythmia
  • Stroke
  • Ischemic Heart Disease Or Coronary Artery Disease (CAD)
  • Other Applications
  • 6.3. Global Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lifescience Companies
  • Healthcare Payers
  • Healthcare Providers

7. Artificial Intelligence In Cardiology Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Cardiology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Intelligence In Cardiology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Intelligence In Cardiology Market

  • 8.1. Asia-Pacific Artificial Intelligence In Cardiology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Intelligence In Cardiology Market

  • 9.1. China Artificial Intelligence In Cardiology Market Overview
  • 9.2. China Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Intelligence In Cardiology Market

  • 10.1. India Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Intelligence In Cardiology Market

  • 11.1. Japan Artificial Intelligence In Cardiology Market Overview
  • 11.2. Japan Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Intelligence In Cardiology Market

  • 12.1. Australia Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Intelligence In Cardiology Market

  • 13.1. Indonesia Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Intelligence In Cardiology Market

  • 14.1. South Korea Artificial Intelligence In Cardiology Market Overview
  • 14.2. South Korea Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Intelligence In Cardiology Market

  • 15.1. Western Europe Artificial Intelligence In Cardiology Market Overview
  • 15.2. Western Europe Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Intelligence In Cardiology Market

  • 16.1. UK Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Intelligence In Cardiology Market

  • 17.1. Germany Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Intelligence In Cardiology Market

  • 18.1. France Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Intelligence In Cardiology Market

  • 19.1. Italy Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.1. Italy Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Intelligence In Cardiology Market

  • 20.1. Spain Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Intelligence In Cardiology Market

  • 21.1. Eastern Europe Artificial Intelligence In Cardiology Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Intelligence In Cardiology Market

  • 22.1. Russia Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Intelligence In Cardiology Market

  • 23.1. North America Artificial Intelligence In Cardiology Market Overview
  • 23.2. North America Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Intelligence In Cardiology Market

  • 24.1. USA Artificial Intelligence In Cardiology Market Overview
  • 24.2. USA Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Intelligence In Cardiology Market

  • 25.1. Canada Artificial Intelligence In Cardiology Market Overview
  • 25.2. Canada Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Intelligence In Cardiology Market

  • 26.1. South America Artificial Intelligence In Cardiology Market Overview
  • 26.2. South America Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Intelligence In Cardiology Market

  • 27.1. Brazil Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Intelligence In Cardiology Market

  • 28.1. Middle East Artificial Intelligence In Cardiology Market Overview
  • 28.2. Middle East Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Intelligence In Cardiology Market

  • 29.1. Africa Artificial Intelligence In Cardiology Market Overview
  • 29.2. Africa Artificial Intelligence In Cardiology Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Intelligence In Cardiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Intelligence In Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Intelligence In Cardiology Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Cardiology Market Competitive Landscape
  • 30.2. Artificial Intelligence In Cardiology Market Company Profiles
    • 30.2.1. Microsoft Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. International Business Machines Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Koninklijke Philips
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Tempus Labs Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Intelligence In Cardiology Market Other Major And Innovative Companies

  • 31.1. Ultromics Ltd
  • 31.2. Bay Labs
  • 31.3. Cleerly Inc.
  • 31.4. RSIP Vision Ltd.
  • 31.5. Idoven
  • 31.6. Cardiologs Technologies Inc.
  • 31.7. Viz.ai
  • 31.8. Ultromics Limited
  • 31.9. Aidoc
  • 31.10. Arterys Inc.
  • 31.11. Zebra Medical Vision
  • 31.12. Vista.ai
  • 31.13. AliveCor
  • 31.14. DiA Imaging Analysis
  • 31.15. Eko Health Inc.

32. Global Artificial Intelligence In Cardiology Market Competitive Benchmarking

33. Global Artificial Intelligence In Cardiology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence In Cardiology Market

35. Artificial Intelligence In Cardiology Market Future Outlook and Potential Analysis

  • 35.1 Artificial Intelligence In Cardiology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Cardiology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Cardiology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer